Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02619669 |
| Title | Neoadjuvant Run-In Study With TAK-228 (MLN0128) Followed by Letrozole/TAK-228 (MLN0128) in Women With High-Risk ER+/HER2- Breast Cancer |
| Recruitment | Withdrawn |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Dartmouth-Hitchcock Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |